Skip to content
DataLookout
Menu

NCT07915323

PET Imaging of the sigma1 Receptor in Healthy Adults

StatusRecruiting
PhasePhase 1
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Test-Blocking measurements, based on quantitative analysis of PET imaging data.
Timeframe: 4 years

Arms and interventions

Test/blocking PET scans for healthy controlsExperimental

A test-blocking study to assess specific binding levels of (S)-\[18F\] FBFP or (R)-\[18F\]FBFP in humans. A total of 10 healthy subjects will undergo two PET scans on two separate days, with the second scan at 4 h (Tmax) after an oral dose of 10 mg donepezil. Each subject will also undergo one MRI scan for anatomical identification of brain regions.

Drugs: (S)-[18F] FBFP or (R)-[18F]FBFP

Sites

1 site in 1 country

  • Yale University PET CenterNew Haven, Connecticut, United States